TSE:6501
TSE:6501Industrials

The Bull Case For Hitachi (TSE:6501) Could Change Following AI-Focused ITxOT And Leadership Moves

Recently, GlobalLogic, a Hitachi Group company, released research on industrial AI adoption, Hitachi Digital Services partnered with Eraneos on ITxOT transformation, and GlobalLogic announced senior leadership changes including a new Chief Synergy and Transformation Officer role. Together, these moves highlight Hitachi’s push to close AI skills gaps, deepen digital engineering within the group, and deliver integrated smart manufacturing solutions. We’ll now examine how Hitachi’s expanded...
TSE:8001
TSE:8001Trade Distributors

ITOCHU (TSE:8001) Valuation Check After New E‑Methane Partnership for Japan’s Carbon‑Neutral Gas Goals

ITOCHU (TSE:8001) is back in focus after teaming up with TotalEnergies, TES, Osaka Gas, and Toho Gas on the Live Oak e methane project in Nebraska, a long dated bet on Japan’s carbon neutral gas ambitions. See our latest analysis for ITOCHU. The market seems to like that direction, with ITOCHU’s 1 year total shareholder return near 30% and a strong 3 year total shareholder return above 140%. In addition, the year to date share price return above 25% suggests momentum is still building. If...
TSE:8031
TSE:8031Trade Distributors

Is Mitsui (TSE:8031) Using Exclusive Biodiesel Rights to Quietly Redefine Its Energy Transition Strategy?

In late November 2025, Optimus Technologies announced it had signed an MOU granting Mitsui & Co. exclusive rights to distribute its Vector System and related 100% biodiesel solutions across Japan, India, and ASEAN markets, aiming to support decarbonization of existing diesel fleets. This exclusive access to biodiesel conversion technology could deepen Mitsui’s role in low-carbon infrastructure, reinforcing its broader energy transition and infrastructure investment ambitions. We’ll now...
TSE:7182
TSE:7182Banks

Could JAPAN POST BANK (TSE:7182) Unlock Hidden Value Through Japan Post’s Real Estate Restructuring?

Earlier this month, activist investor Palliser Capital urged Japan Post Holdings to consolidate its sprawling real estate operations into a dedicated unit and consider options such as a spinoff after a strategic review. The push highlights how Japan Post’s property portfolio, long treated as a supporting asset, could become a central source of potential value if restructuring gains political and customer backing. With this backdrop, we will explore how Palliser’s call for a real estate...
TSE:6981
TSE:6981Electronic

Will Murata’s SiC-Ready High-Voltage MLCC Push Change Murata Manufacturing's (TSE:6981) Narrative?

Earlier this month, Murata Manufacturing launched and began mass production of a compact 1.25kV, up to 15nF C0G multilayer ceramic capacitor aimed at EV onboard chargers and high-performance consumer power supplies. By aligning this high-voltage MLCC with the industry’s move toward SiC MOSFET-based power conversion, Murata is directly targeting a technically demanding and fast-evolving segment of the electronics supply chain. We’ll now examine how this push into SiC-ready high-voltage MLCCs...
TSE:1928
TSE:1928Consumer Durables

Should Sekisui House’s Higher FY2026 Guidance and Dividend Hike Require Action From Sekisui House (TSE:1928) Investors?

In December 2025, Sekisui House, Ltd. issued consolidated earnings guidance for the fiscal year ending January 31, 2026, projecting net sales of ¥4.33 trillion, operating profit of ¥340.00 billion and profit attributable to owners of parent of ¥232.00 billion, equivalent to basic earnings per share of ¥357.97. The company also raised its second-quarter-end dividend to ¥72 per share from ¥64 a year earlier, signaling management’s confidence and a stronger cash return stance to...
TSE:6361
TSE:6361Machinery

The Bull Case For Ebara (TSE:6361) Could Change Following Goldman’s Semiconductor Pivot Call On Profits

Earlier this week, Goldman Sachs initiated coverage of Ebara Corp., highlighting strong growth potential in its semiconductor equipment business, especially chemical mechanical polishing systems within the Precision Machinery segment. The bank’s view that semiconductor-related products could account for more than 60% of Ebara’s operating profits within a few years underscores how central this segment has become to the company’s future earnings mix. We’ll now explore how this endorsement of...
TSE:9432
TSE:9432Telecom

NTT (TSE:9432) Valuation Check as New AIVista Unit and Photonic AI Breakthrough Expand Its Tech Ambitions

NTT (TSE:9432) is stepping up its AI ambitions, launching NTT DATA AIVista in Silicon Valley under CEO Dr. Bratin Saha, while its labs showcase a new photonic processor for optical neural network inference. See our latest analysis for NTT. Despite the buzz around AIVista and its photonic processor breakthrough, the latest share price of ¥155.1 comes with a modest year to date share price return of around negative 1 percent. The five year total shareholder return of roughly 71 percent suggests...
TSE:6371
TSE:6371Machinery

How Investors Are Reacting To Tsubakimoto Chain (TSE:6371) New AI Logistics Automation Partnership

KIOXIA America announced that Kioxia, Tsubakimoto Chain and EAGLYS have formed a collaboration to develop AI-driven image recognition technology that automates identification of products in logistics workflows, with the jointly built system already showcased at the December 2025 International Robot Exhibition in Tokyo. The project is interesting because it links Tsubakimoto Chain’s conveyor and logistics expertise with Kioxia’s Memory-Centric AI and EAGLYS’s image analytics to address...
TSE:7911
TSE:7911Commercial Services

Can TOPPAN Holdings (TSE:7911) Recasting Its Electronics Portfolio Deepen Its Semiconductor Packaging Moat?

Earlier this week, TOPPAN Holdings Inc. held a board meeting to consider a new executive structure, while subsidiary TOPPAN Inc. and Tekscend Photomask Corp. prepared to showcase advanced semiconductor photomasks, packaging technologies, and FC-BGA substrates targeting AI and data center demand at SEMICON Japan 2025. Together with an Electronics Business Strategy Briefing for analysts and investors, these moves highlight TOPPAN’s push to reposition its electronics business around...
TSE:8306
TSE:8306Banks

Has Mitsubishi UFJ Financial Group’s Strong Multi Year Rally Left Much Upside in 2025?

If you are wondering whether Mitsubishi UFJ Financial Group still offers good value after such a strong run, or if you are arriving too late, this breakdown is designed to help you decide with a cool head. The stock has slipped 2.7% over the last week but is still up 5.4% over the past month, 31.7% year to date, 36.5% over 1 year, and an eye catching 254.1% over 3 years and 557.6% over 5 years. This naturally raises the question of how much upside is left from here. Recent market attention...
TSE:3659
TSE:3659Entertainment

Did Nexon’s AI Ethics Stance in Arc Raiders Just Shift NEXON's (TSE:3659) Investment Narrative?

Nexon’s CEO Junghun Lee recently argued that “every game company” now uses AI, while stressing that human creativity still separates standout titles from average ones, as debate intensified over the ethical limits of AI in its hit game Arc Raiders. Following criticism, Embark Studios clarified that Arc Raiders relies on machine learning and reinforcement learning rather than generative AI, putting Nexon’s broader technology choices and stance on AI ethics under a spotlight. We’ll now examine...
TSE:3663
TSE:3663Software

High Growth Tech Stocks To Watch In Asia December 2025

As Asian markets navigate a complex landscape marked by mixed economic indicators and evolving investor sentiment, the region's technology sector continues to capture attention with its potential for high growth. In this environment, identifying promising tech stocks involves looking for companies that demonstrate resilience and innovation amidst shifting global trends and local challenges.
TSE:4506
TSE:4506Pharmaceuticals

Hematology Pipeline Advances Could Be A Game Changer For Sumitomo Pharma (TSE:4506)

In December 2025, Sumitomo Pharma America presented updated Phase 1/2 clinical data at the 67th American Society of Hematology Annual Meeting in Orlando, highlighting its investigational oral menin inhibitor enzomenib for relapsed or refractory acute leukemia and PIM1 kinase inhibitor nuvisertib for relapsed or refractory myelofibrosis. The promising response rates and favorable safety profiles reported for these two early-stage oncology candidates point to a strengthening hematology...